# InspireMD, Inc.: filings

NSPR · Nasdaq · CIK 1433607 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nspr.md) · [Financials](/companies/nspr/financials.md) · [Filings](/companies/nspr/filings.md) · [Insiders](/companies/nspr/insiders.md)

## Reports and events: 527 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 378, 4 280, 10-Q 50, CORRESP 46, S-1/A 35, SC 13G/A 31, UPLOAD 30, SC 13G 29, 3 27, DEF 14A 21, EFFECT 20, D 19, SCHEDULE 13G/A 17, 424B5 16, DEFA14A 16, 10-K 15, 424B3 14, S-8 12, PRE 14A 11, S-1 10, 4/A 9, S-3 8, 424B4 7, 8-A12B 6, 8-K/A 6, FWP 6, ARS 5, SC 13D 5, SC 13D/A 4, SCHEDULE 13G 4, CERTNYS 3, 10-KT 2, 10-KT/A 2, 25 2, CERT 2, POS AM 2, SCHEDULE 13D 2, 25-NSE 1, 3/A 1, 8-A12B/A 1, 8-A12G 1, CT ORDER 1, PRER14A 1, RW 1, S-1MEF 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 09:12 ET | [8-K](/filings/0001493152-26-043488.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043488 |
| 2026-08-17 | 07:05 ET | [8-K](/filings/0001493152-26-038624.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038624 |
| 2026-08-14 | 16:30 ET | [10-Q](/filings/0001493152-26-038438.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038438 |
| 2026-07-29 | 17:00 ET | [8-K](/filings/0001493152-26-035220.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035220 |
| 2026-07-23 | 17:00 ET | [8-K](/filings/0001493152-26-034430.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-034430 |
| 2026-07-02 | 17:00 ET | [8-K](/filings/0001493152-26-031945.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031945 |
| 2026-06-11 | 08:05 ET | [8-K](/filings/0001493152-26-028221.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028221 |
| 2026-06-03 | 16:05 ET | [8-K](/filings/0001493152-26-027045.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-027045 |
| 2026-05-22 | 16:05 ET | [8-K](/filings/0001493152-26-025017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-025017 |
| 2026-05-07 | 08:53 ET | [10-Q](/filings/0001493152-26-021636.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021636 |
| 2026-05-04 | 16:05 ET | [8-K](/filings/0001493152-26-021105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-021105 |
| 2026-05-01 | 16:07 ET | [8-K](/filings/0001493152-26-020891.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020891 |
| 2026-04-24 | 17:00 ET | [SCHEDULE 13D](/filings/0001493152-26-018952.md) | Ownership report, active investor | 0001493152-26-018952 |
| 2026-04-20 | 16:30 ET | [DEF 14A](/filings/0001493152-26-018103.md) | Proxy statement, period 2026-04-20 | 0001493152-26-018103 |
| 2026-04-03 | 16:01 ET | [8-K](/filings/0001493152-26-015127.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-015127 |
| 2026-03-18 | 08:34 ET | [10-K](/filings/0001493152-26-010886.md) | Annual report, period 2025-12-31 | 0001493152-26-010886 |
| 2026-03-18 | 07:18 ET | [8-K](/filings/0001493152-26-010791.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-010791 |
| 2026-03-04 | 17:15 ET | [8-K](/filings/0001493152-26-008894.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-008894 |
| 2025-12-19 | 16:15 ET | [8-K](/filings/0001493152-25-028558.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-028558 |
| 2025-11-10 | 16:06 ET | [10-Q](/filings/0001493152-25-021503.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021503 |
| 2025-11-04 | 16:06 ET | [8-K](/filings/0001493152-25-020718.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020718 |
| 2025-10-29 | 16:30 ET | [SCHEDULE 13D](/filings/0001493152-25-020078.md) | Ownership report, active investor | 0001493152-25-020078 |
| 2025-10-29 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001493152-25-020079.md) | Ownership report, active investor, amended | 0001493152-25-020079 |
| 2025-09-17 | 08:00 ET | [8-K](/filings/0001493152-25-013828.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013828 |
| 2025-09-08 | 16:05 ET | [8-K/A](/filings/0001493152-25-012805.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-012805 |
| 2025-08-05 | 09:01 ET | [8-K](/filings/0001641172-25-022159.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022159 |
| 2025-08-04 | 16:05 ET | [10-Q](/filings/0001641172-25-022040.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022040 |
| 2025-07-31 | 08:35 ET | [8-K](/filings/0001641172-25-021675.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021675 |
| 2025-07-09 | 07:05 ET | [8-K](/filings/0001641172-25-018302.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-018302 |
| 2025-06-24 | 16:21 ET | [8-K](/filings/0001641172-25-016293.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016293 |
| 2025-06-13 | 09:05 ET | [8-K](/filings/0001641172-25-014986.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014986 |
| 2025-06-03 | 16:10 ET | [8-K](/filings/0001641172-25-013433.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013433 |
| 2025-06-03 | 16:05 ET | [8-K](/filings/0001641172-25-013427.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013427 |
| 2025-05-09 | 07:09 ET | [8-K](/filings/0001641172-25-009364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009364 |
| 2025-05-08 | 16:05 ET | [10-Q](/filings/0001641172-25-009250.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009250 |
| 2025-04-15 | 16:15 ET | [DEF 14A](/filings/0001641172-25-004800.md) | Proxy statement, period 2024-12-31 | 0001641172-25-004800 |
| 2025-03-12 | 07:43 ET | [8-K](/filings/0001493152-25-009936.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009936 |
| 2025-03-12 | 06:05 ET | [10-K](/filings/0001493152-25-009909.md) | Annual report, period 2024-12-31 | 0001493152-25-009909 |
| 2024-12-12 | 07:22 ET | [8-K](/filings/0001493152-24-049727.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-049727 |
| 2024-12-09 | 08:03 ET | [8-K](/filings/0001493152-24-049199.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049199 |
| 2024-11-25 | 16:17 ET | [8-K](/filings/0001493152-24-047617.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047617 |
| 2024-11-12 | 09:27 ET | [8-K](/filings/0001493152-24-044599.md) | 7.01 Regulation FD disclosure | 0001493152-24-044599 |
| 2024-11-12 | 09:00 ET | [10-Q](/filings/0001493152-24-044578.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044578 |
| 2024-10-15 | 07:10 ET | [8-K](/filings/0001493152-24-041036.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041036 |
| 2024-10-07 | 07:10 ET | [8-K](/filings/0001493152-24-039640.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001493152-24-039640 |
| 2024-10-01 | 16:05 ET | [8-K](/filings/0001493152-24-039017.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-039017 |
| 2024-09-16 | 07:32 ET | [8-K](/filings/0001493152-24-036293.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-036293 |
| 2024-08-06 | 08:42 ET | [8-K](/filings/0001493152-24-030372.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030372 |
| 2024-08-05 | 16:30 ET | [10-Q](/filings/0001493152-24-030265.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030265 |
| 2024-07-01 | 07:00 ET | [8-K](/filings/0001493152-24-025714.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-025714 |

Page 1 of 11. [Older](/companies/nspr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.